Developing a mouse model of acute bacterial rhinosinusitis.
The objective of this study is to establish a mouse model of acute bacterial rhinosinusitis. 179 healthy male BALB/c mice were divided into four groups in this randomized and controlled study. Sponge slivers impregnated with methicillin-resistant Staphylococcus aureus (MRSA COL) suspension were inserted into the right nasal cavities for group A; sponge slivers impregnated with sterile saline were inserted into the right nasal cavities for group B; group C mice were inoculated with MRSA COL suspension in right nasal cavities; group D was control group without any treatment. Mice were killed on days 1, 4, 7 and 14, respectively. Nasal lavage fluid was prepared for microbiological culture. Histological examinations of nasal specimens were performed to observe the severity of inflammatory reaction. Acute bacterial rhinosinusitis was induced in all group A mice. Less severe inflammation was seen in partial group B mice compared with that in group A mice (P ≤ 0.05). No inflammatory reaction was found in group C and D mice. In conclusion, a mouse model of acute bacterial rhinosinusitis has been developed successfully using an easier, less invasive and potentially more reversible technique than those used in previous studies.
Department of Otolaryngology, Shengjing Hospital of China Medical University, Sanhao Street 36, Shenyang, Liaoning, China. jinmingzhu1984@sohu.com
Mingzhu
M
Jin
Zhaowei
Z
Gu
Zhigang
Z
Bian
Jing
J
Yang
Zhiwei
Z
Cao
Xiaofeng
X
Yu
Genyan
G
Guo
D000208:Acute Disease; D000818:Animals; D004195:Disease Models, Animal; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification* / Q000472:pathogenicity; D051379:Mice; D008807:Mice, Inbred BALB C; D017817:Nasal Lavage Fluid / Q000382:microbiology*; D009297:Nasal Mucosa / Q000382:microbiology / Q000473:pathology; D012220:Rhinitis / Q000382:microbiology* / Q000473:pathology; D012720:Severity of Illness Index; D012852:Sinusitis / Q000382:microbiology* / Q000473:pathology; D013203:Staphylococcal Infections / Q000382:microbiology* / Q000473:pathology
N Engl J Med. 2003 Apr 3;348(14):1342-7
12672861
Arch Otolaryngol Head Neck Surg. 1998 Nov;124(11):1227-32
9821924
Trends Microbiol. 2001 Dec;9(12):605-10
11728874
Am J Rhinol. 2008 Jul-Aug;22(4):343-8
18702895
Laryngoscope. 2004 Feb;114(2):273-8
14755202
Infect Immun. 1999 Oct;67(10):5001-6
10496870
N Engl J Med. 2001 Jan 4;344(1):11-6
11136954
Clin Diagn Lab Immunol. 2001 Nov;8(6):1064-9
11687441
Arch Otolaryngol Head Neck Surg. 2001 Jun;127(6):657-64
11405864
Antimicrob Agents Chemother. 2003 May;47(5):1589-97
12709327
Infect Immun. 2006 Apr;74(4):2145-53
16552044
Infect Immun. 2005 Mar;73(3):1847-51
15731086
Laryngoscope. 2008 Jun;118(6):1076-81
18388772
J Antimicrob Chemother. 2004 Sep;54(3):648-53
15282239
Clin Microbiol Rev. 1997 Jul;10(3):505-20
9227864